Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Sphingolipids Function as Downstream Effectors of a Fungal PAQR

Nancy Y. Villa, Brian R. Kupchak, Ibon Garitaonandia, Jessica L. Smith, Emilio Alonso, Charlene Alford, L. Ashley Cowart, Yusuf A. Hannun and Thomas J. Lyons
Molecular Pharmacology April 2009, 75 (4) 866-875; DOI: https://doi.org/10.1124/mol.108.049809
Nancy Y. Villa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian R. Kupchak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ibon Garitaonandia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica L. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilio Alonso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlene Alford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Ashley Cowart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuf A. Hannun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas J. Lyons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

The Izh2p protein from Saccharomyces cerevisiae belongs to the newly characterized progestin and adipoQ receptor (PAQR) superfamily of receptors whose mechanism of signal transduction is still unknown. Izh2p functions as a receptor for the plant PR-5 defensin osmotin and has pleiotropic effects on cellular biochemistry. One example of this pleiotropy is the Izh2p-dependent repression of FET3, a gene involved in iron-uptake. Although the physiological purpose of FET3 repression by Izh2p is a matter of speculation, it provides a reporter with which to probe the mechanism of signal transduction by this novel class of receptor. Receptors in the PAQR family share sequence similarity with enzymes involved in ceramide metabolism, which led to the hypothesis that sphingolipids are involved in Izh2p-dependent signaling. In this study, we demonstrate that drugs affecting sphingolipid metabolism, such as d-erythro-MAPP and myriocin, inhibit the effect of Izh2p on FET3. We also show that Izh2p causes an increase in steady-state levels of sphingoid base. Moreover, we show that Izh2p-independent increases in sphingoid bases recapitulate the effect of Izh2p on FET3. Finally, our data indicate that the Pkh1p and Pkh2p sphingoid base-sensing kinases are essential components of the Izh2p-dependent signaling pathway. In conclusion, our data indicate that Izh2p produces sphingoid bases and that these bioactive lipids probably function as the second messenger responsible for the effect of Izh2p on FET3.

Footnotes

  • This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant R21-DK074812]; the National Institutes of Health National Institute of General Medical Sciences [Grant GM63265]; and the Department of Veteran's Affairs Merit Review Entry Program.

  • N.Y.V. and B.R.K. contributed equally to the preparation of the manuscript.

  • ABBREVIATIONS: PAQR, progestin and adipoQ receptor; IZH, implicated in zinc homeostasis; d-erythro-MAPP, d-(2-myristoylamino)-3-phenylpropanol; FET, ferric iron transporter; PHS, phytosphingosine; GPCR, G-protein-coupled receptor; PKA, cAMP-dependent protein kinase; LIM, low iron medium; N,N-DMS, N,N-dimethylsphingosine; FB1, fumonisin B1; DMSO, dimethyl sulfoxide; HPLC, high-performance liquid chromatography; TLC, thin-layer chromatography; TM, transmembrane domain; AlkCer, alkaline ceramidase; AMPK, AMP-activated protein kinase; PDK1, phosphoinositide-dependent kinase 1; WT, wild type.

  • ↵ Embedded Image The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

  • ↵1 Current affiliation: Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida.

  • ↵2 Current affiliation: Department of Kinesiology, University of Connecticut, Storrs, Connecticut.

  • ↵3 Current affiliation: The Center for Regenerative Medicine, The Scripps Research Institute, La Jolla, California.

  • ↵4 Current affiliation: HIV Drug Resistance Program, National Institutes of Health, Frederick, Maryland.

    • Received June 19, 2008.
    • Accepted December 8, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 75 (4)
Molecular Pharmacology
Vol. 75, Issue 4
1 Apr 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sphingolipids Function as Downstream Effectors of a Fungal PAQR
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Sphingolipids Function as Downstream Effectors of a Fungal PAQR

Nancy Y. Villa, Brian R. Kupchak, Ibon Garitaonandia, Jessica L. Smith, Emilio Alonso, Charlene Alford, L. Ashley Cowart, Yusuf A. Hannun and Thomas J. Lyons
Molecular Pharmacology April 1, 2009, 75 (4) 866-875; DOI: https://doi.org/10.1124/mol.108.049809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Sphingolipids Function as Downstream Effectors of a Fungal PAQR

Nancy Y. Villa, Brian R. Kupchak, Ibon Garitaonandia, Jessica L. Smith, Emilio Alonso, Charlene Alford, L. Ashley Cowart, Yusuf A. Hannun and Thomas J. Lyons
Molecular Pharmacology April 1, 2009, 75 (4) 866-875; DOI: https://doi.org/10.1124/mol.108.049809
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics